VERTEX PHARMACEUTICALS INCORPORATED Funds and ETFs Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 429.9 USD | +1.69% |
|
+6.81% | +5.66% |
| 11:53am | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
| 05-10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
ETFs positioned on Vertex Pharmaceuticals Incorporated
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.22% | 205 M€ | -.--% | ||
| 0.22% | 264 M€ | -.--% | - | |
| 0.22% | 187 M€ | +9.40% | - | |
| 0.22% | 20 M€ | +1.33% | - | |
| 0.22% | 477 M€ | +11.35% | ||
| 0.21% | 57 M€ | +20.49% | - | |
| 0.20% | 7 M€ | +0.11% | - | |
| 0.20% | 7 M€ | +5.61% | - | |
| 0.20% | 32 M€ | +1.38% | - | |
| 0.20% | 17 M€ | +5.61% | - | |
| 0.19% | 9 M€ | +9.07% | - | |
| 0.19% | 37 M€ | -.--% | ||
| 0.18% | 14 M€ | +16.19% | - | |
| 0.17% | 15 M€ | -1.62% | - | |
| 0.17% | 284 M€ | -.--% | ||
| 0.16% | 607 M€ | +0.05% | - | |
| 0.16% | 1,166 M€ | +0.26% | - | |
| 0.16% | 206 M€ | -.--% | ||
| 0.16% | 23 M€ | -.--% | - | |
| 0.16% | 786 M€ | -.--% | ||
| 0.16% | 0 M€ | 0.00% | - | |
| 0.16% | 2,517 M€ | +11.91% | - | |
| 0.15% | 283 M€ | +19.39% | ||
| 0.14% | 571 M€ | +6.88% | - | |
| 0.14% | 414 M€ | +11.88% | - | |
| 0.14% | 1,006 M€ | -.--% | - |
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Calendar
2024-05-15
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
429.9
USD
Average target price
462.6
USD
Spread / Average Target
+7.59%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.66% | 111B | |
| +11.23% | 105B | |
| -12.15% | 22.34B | |
| -2.79% | 21.93B | |
| -6.13% | 18.59B | |
| -36.52% | 18.12B | |
| -10.09% | 16.96B | |
| +3.33% | 13.7B | |
| +36.58% | 12.45B | |
| +288.77% | 7.98B |
- Stock Market
- Equities
- VRTX Stock
- Funds and ETFs Vertex Pharmaceuticals Incorporated